VIE Capital Project Performance Analyst
UCB Pharma
VIE Capital Project Performance Analyst
UCB Pharma
Biopharmaceuticals for neurology and immunology therapies
Make your mark for patients
UCB is an international biopharmaceutical company primarily engaged in the research, development, and commercialization of pharmaceutical and biotechnological products. It specializes in researching therapeutic solutions for patients suffering from severe diseases, treated by specialists, particularly in the fields of the central nervous system (including epilepsy) and inflammation (including allergies).
The Braine-l'Alleud site specializes in chemical synthesis, development, manufacturing, and packaging of pharmaceutical products.
More information at: www.ucb.com
Your mission:
Your mission will be to support the Engineering Delivery organisation in its continuous improvement and transformation initiatives, with a particular focus on project delivery excellence. This assignment will provide broad exposure to investment projects, engineering governance, organisational transformation and performance management, while contributing to strategic initiatives that support the ambitions of the Engineering department.
Role and Missions:
Your Profile:
Please note that the strict eligibility conditions for this program are as follows:
If you do not meet all of these conditions, we will not be able to consider your application.
Biopharmaceuticals for neurology and immunology therapies
UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.
Explore more opportunities at UCB Pharma